{"id":"W4200101921","doi":"10.1016/j.ejps.2021.106097","title":"Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum","year":2021,"lang":"en","type":"article","venue":"European Journal of Pharmaceutical Sciences","topic":"Research on Leishmaniasis Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Leishmania infantum; Miltefosine; In vivo; Visceral leishmaniasis; Pharmacology; Leishmaniasis; Oral administration; Leishmania; Adverse effect; Drug; Chemistry; Antiprotozoal; Medicine; In vitro; Immunology; Biology; Biochemistry; Biotechnology; Parasite hosting","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002687332,0.0001539189,0.0004595995,0.0002083289,0.0001245487,0.00006936728,0.0002859157,0.00002818345,0.0002523395],"category_scores_gemma":[0.001523955,0.0001122807,0.0001378864,0.0007920976,0.0007526471,0.0003773936,0.0001500803,0.0004919106,0.000004285195],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007036274,"about_ca_system_score_gemma":0.0006538348,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005126778,"about_ca_topic_score_gemma":0.0000233399,"domain_scores_codex":[0.9968569,0.0008484605,0.0006335523,0.0002491843,0.001025047,0.0003868107],"domain_scores_gemma":[0.9986457,0.0001661447,0.0002931922,0.0001344755,0.0004427921,0.000317742],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0008781237,0.0003922285,0.03814162,0.0001284836,0.0001059543,0.002801563,0.0004689346,0.00004046955,0.9271995,0.0001258238,0.002419724,0.02729759],"study_design_scores_gemma":[0.002790415,0.001324455,0.1803362,0.0003602495,0.0000789376,0.0006987129,0.0007308611,0.0005912866,0.7829576,0.00003507883,0.02990892,0.0001873295],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9837232,0.0006278633,0.00005210258,0.003189832,0.0003629484,0.0001163024,0.00001047781,0.00001025996,0.01190698],"genre_scores_gemma":[0.9976195,0.0007746576,0.0009412392,0.0002483346,0.0002515485,5.667898e-7,6.182665e-7,0.00001175925,0.0001517467],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1442419,"threshold_uncertainty_score":0.4578673,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06840887991818718,"score_gpt":0.3753814602631708,"score_spread":0.3069725803449836,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}